Zimbabwe has turned down a significant American health deal worth 367 million US dollars (£272m) spanning five years over the United States' demand for confidential data.
This rejection became public after a internal memorandum from December was leaked, which showed Head of State Emmerson Mnangagwa deemed the agreement was "lopsided".
An official spokesperson has since explained that the US was requesting health data for research and profit while was unwilling to guarantee the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable process of scaling back our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had donated over $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged more dialogue to reach a deal agreeable to all parties so the nation's critical HIV programme can proceed.
Broader Implications
This rejection comes after a similar situation in neighbouring Kenya, where a high court halted a similar health funding agreement after legal challenges were filed about the safety of citizens' medical information.
Since returning to office last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump stated its spending was "inefficient" and his government was seeking direct bilateral agreements to boost transparency and accountability.
As per statements, 16 nations in Africa have to date signed these new agreements, representing more than $18.3bn in new funding.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this partnership might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy through US-supported initiatives," the Ambassador added.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"Our nation was requested to surrender its genetic material and health information indefinitely, with no equivalent guarantee of access to any medical innovations – like new medicines or tests – that could be developed from that shared data," his statement read.
"Effectively, our nation would supply the basic resources for medical research with no assurance that the end products would be accessible to our citizens if a new pandemic arise."
National Interest and International Frameworks
He also pointed out that the American exit from the global health body and its push of one-on-one health agreements were upending structures already established via the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing system created to deal with potential global health emergencies.
"This framework is designed to ensure that when a nation contributes its samples, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to create them."
These objections over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how subsequent co-operation could be structured in a manner that respects the independence and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but suggested that talks should continue considering much of the country's Aids initiatives relied on international support.
"If specific concerns exist, including those relating to data governance or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," it commented.
The situation underscores the complex tensions between accepting crucial foreign assistance and protecting national sovereignty in an ever more data-driven world.